Milos D Miljkovic (Milos Miljkovic)

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 5

Top Topics

Acute Myeloid Leukemia

Diffuse Large B Cell Lymphoma

Neoadjuvant Chemotherapy

Top Venues

Proceedings of the National Academy of Sciences of the United States of America

Critical reviews in clinical laboratory sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Anusara Daenthanasanmak, Richard N Bamford, Makoto Yoshioka, Shyh-Ming Yang, Philip Homan, Baktiar O Karim, Bonita R Bryant, Michael N Petrus, Craig J Thomas, Patrick L Green, Milos D Miljkovic, Kevin C Conlon, Thomas A Waldmann
Triple combination of BET plus PI3K and NF-κB inhibitors exhibit synergistic activity in adult T-cell leukemia/lymphoma. Blood advances 6 (7) (2022)
Nadia Güell, Pablo Mozas, Alba Jimenez-Rueda, Milos D Miljkovic, Jordi Juncà, Marc Sorigue
Methodological and conceptual challenges to the flow cytometric classification of leukemic lymphoproliferative disorders. Critical reviews in clinical laboratory sciences (2022)
Dai Chihara, Milos D Miljkovic, Swaminathan P Iyer, Francisco Vega
Targeted based therapy in nodal T-cell lymphomas. Leukemia 35 (4) (2021)
Milos D Miljkovic, Christopher Melani, Stefania Pittaluga, Rahul Lakhotia, Nicole Lucas, Allison Jacob, Erik Yusko, Elaine S Jaffe, Wyndham H Wilson, Mark J Roschewski
Next-generation sequencing-based monitoring of circulating tumor DNA reveals clonotypic heterogeneity in untreated PTCL. Blood advances 5 (20) (2021)
Yunlong He, Nagesh Pasupala, Huijun Zhi, Batsuhk Dorjbal, Imran Hussain, Hsiu-Ming Shih, Sharmistha Bhattacharyya, Roopa Biswas, Milos D Miljkovic, Oliver John Semmes, Thomas A Waldmann, Andrew L Snow, Chou-Zen Giam
NF-κB-induced R-loop accumulation and DNA damage select for nucleotide excision repair deficiencies in adult T cell leukemia. Proceedings of the National Academy of Sciences of the United States of America 118 (10) (2021)